Frankfurt - Delayed Quote • EUR
Nxera Pharma Co., Ltd. (JSS.F)
At close: April 19 at 8:26 AM GMT+2
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
-5,273,000.00
-5,273,000.00
9,952,000.00
7,095,000.00
4,672,000.00
Investing Cash Flow
-63,791,000.00
-63,791,000.00
1,043,000.00
278,000.00
-150,000.00
Financing Cash Flow
48,329,000.00
48,329,000.00
-4,887,000.00
11,123,000.00
20,278,000.00
End Cash Position
49,065,000.00
49,065,000.00
66,557,000.00
60,087,000.00
40,008,000.00
Capital Expenditure
-851,000.00
-851,000.00
-303,000.00
-201,000.00
-105,000.00
Issuance of Capital Stock
9,983,000.00
9,983,000.00
--
600,000.00
5,145,000.00
Issuance of Debt
71,608,000.00
71,608,000.00
--
29,855,000.00
15,902,000.00
Repayment of Debt
-32,750,000.00
-32,750,000.00
--
-18,958,000.00
--
Free Cash Flow
-6,124,000.00
-6,124,000.00
9,649,000.00
6,894,000.00
4,567,000.00
12/31/2020 - 2/8/2019
Yahoo Finance Plus Essential access required. Unlock Access